Hyperglycemia associated with propranolol and chlorpropamide coadministration

Area of Science:

• Endocrinology
• Pharmacology
• Internal Medicine

Background:

• Acute pancreatitis management can be complex.
• Comorbidities like diabetes mellitus and arterial hypertension require careful pharmacological consideration.
• Beta-blockers and oral hypoglycemic agents are commonly used in managing these conditions.

Observation:

• A 59-year-old male patient with acute pancreatitis presented with concurrent diabetes mellitus and hypertension.
• Initial treatment with propranolol and insulin was well-tolerated.
• Switching insulin to chlorpropamide resulted in a significant increase in blood glucose levels.

Findings:

• The observed hyperglycemia was attributed to a potential drug interaction between propranolol and chlorpropamide.
• Propranolol's antagonistic action at the pancreatic level was hypothesized to interfere with chlorpropamide's efficacy.
• This interaction highlights the importance of considering beta-blocker effects on glucose-lowering medications.

Implications:

• Clinicians should be aware of the potential for propranolol to interfere with oral sulfonylurea agents like chlorpropamide.
• Careful monitoring of blood glucose is essential when these medications are co-prescribed.
• Further research may be warranted to elucidate the precise mechanisms of this interaction.